[Breaking] GSK, "Antibody Treatment 'Sotrovimab' Shows Effectiveness Against Omicron Variant in Preclinical Trials" View original image

[Asia Economy Reporter Lee Chunhee]



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing